In myelodysplastic syndrome-derived acute myeloid leukemia cells, CBP/p300 promote the expression of ribosomal genes and CBP/p300 inhibition reduces global protein synthesis, leading to leukemia cell death 76. The gene discussed is CREBBP; the disease is acute myeloid leukemia.